FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765559122> ?p ?o ?g. }

• W2765559122 endingPage "6684" @default.
• W2765559122 startingPage "6676" @default.
• W2765559122 abstract "Most vaccinations are performed by intramuscular injection with a needle and syringe. However, this method is not ideal due to limitations, such as the risk of needle-stick injury, the requirement for trained personnel to give injections and the need to reconstitute lyophilized vaccines. Therefore, we tested an alternative delivery technology that overcomes the problems with needle and syringe. The Nanopatch™ is an array of 10,000 silicon micro-projections per cm2 that can be dry-coated with vaccine for skin delivery. The high number and density of micro-projections means that high velocity application is required to achieve consistent skin penetration. Before clinically testing a vaccine Nanopatch, this study tests the safety, tolerability and acceptability/utility of uncoated and excipient-coated Nanopatches in healthy adults. Nanopatches were applied to skin of the upper arm and volar forearm and left in contact with the skin for two minutes before removal. The application sites were assessed for local skin response over 28 days. Acceptability interviews were also performed. No unexpected adverse events directly related to the Nanopatch application were reported. All applications of the Nanopatch resulted in an expected erythema response which faded between days 3 and 7. In some subjects, some skin discolouration was visible for several days or up to 3 weeks after application. The majority (83%) of subjects reported a preference for the Nanopatch compared to the needle and syringe and found the application process to be simple and acceptable. On a pain scale from 0 to 10, 78% of applications were scored “0” (no pain) with the average scores for less than 1. The results from this study demonstrate the feasibility of the Nanopatch to improve vaccination by showing that application of the product without vaccine to human skin is safe, tolerable and preferred to needle and syringe administration. Clinical trial registry ID: ACTRN1261500083549." @default.
• W2765559122 created "2017-11-10" @default.
• W2765559122 creator A5011443173 @default.
• W2765559122 creator A5012921828 @default.
• W2765559122 creator A5015270214 @default.
• W2765559122 creator A5025732042 @default.
• W2765559122 creator A5045348624 @default.
• W2765559122 creator A5064780677 @default.
• W2765559122 creator A5086563558 @default.
• W2765559122 date "2017-12-01" @default.
• W2765559122 modified "2023-10-17" @default.
• W2765559122 title "Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects" @default.
• W2765559122 cites W1488116025 @default.
• W2765559122 cites W1885356817 @default.
• W2765559122 cites W1979290264 @default.
• W2765559122 cites W1992441460 @default.
• W2765559122 cites W1994766058 @default.
• W2765559122 cites W2006066267 @default.
• W2765559122 cites W2014506882 @default.
• W2765559122 cites W2022065543 @default.
• W2765559122 cites W2031023460 @default.
• W2765559122 cites W2034166814 @default.
• W2765559122 cites W2041250960 @default.
• W2765559122 cites W2041913794 @default.
• W2765559122 cites W2042179919 @default.
• W2765559122 cites W2043308790 @default.
• W2765559122 cites W2056347583 @default.
• W2765559122 cites W2059316854 @default.
• W2765559122 cites W2081366054 @default.
• W2765559122 cites W2087002087 @default.
• W2765559122 cites W2088368520 @default.
• W2765559122 cites W2093264881 @default.
• W2765559122 cites W2093692060 @default.
• W2765559122 cites W2103742770 @default.
• W2765559122 cites W2180164052 @default.
• W2765559122 cites W2214187867 @default.
• W2765559122 cites W2293145130 @default.
• W2765559122 cites W2325727928 @default.
• W2765559122 cites W2326904022 @default.
• W2765559122 cites W2409984077 @default.
• W2765559122 cites W2421290276 @default.
• W2765559122 cites W2473536856 @default.
• W2765559122 cites W2592692387 @default.
• W2765559122 cites W2732601320 @default.
• W2765559122 cites W4250350090 @default.
• W2765559122 cites W4250928742 @default.
• W2765559122 doi "https://doi.org/10.1016/j.vaccine.2017.10.021" @default.
• W2765559122 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29074201" @default.
• W2765559122 hasPublicationYear "2017" @default.
• W2765559122 type Work @default.
• W2765559122 sameAs 2765559122 @default.
• W2765559122 citedByCount "33" @default.
• W2765559122 countsByYear W27655591222018 @default.
• W2765559122 countsByYear W27655591222019 @default.
• W2765559122 countsByYear W27655591222020 @default.
• W2765559122 countsByYear W27655591222021 @default.
• W2765559122 countsByYear W27655591222022 @default.
• W2765559122 countsByYear W27655591222023 @default.
• W2765559122 crossrefType "journal-article" @default.
• W2765559122 hasAuthorship W2765559122A5011443173 @default.
• W2765559122 hasAuthorship W2765559122A5012921828 @default.
• W2765559122 hasAuthorship W2765559122A5015270214 @default.
• W2765559122 hasAuthorship W2765559122A5025732042 @default.
• W2765559122 hasAuthorship W2765559122A5045348624 @default.
• W2765559122 hasAuthorship W2765559122A5064780677 @default.
• W2765559122 hasAuthorship W2765559122A5086563558 @default.
• W2765559122 hasBestOaLocation W27655591221 @default.
• W2765559122 hasConcept C118552586 @default.
• W2765559122 hasConcept C136229726 @default.
• W2765559122 hasConcept C141071460 @default.
• W2765559122 hasConcept C197934379 @default.
• W2765559122 hasConcept C2777239854 @default.
• W2765559122 hasConcept C2778375690 @default.
• W2765559122 hasConcept C2778571141 @default.
• W2765559122 hasConcept C2779121184 @default.
• W2765559122 hasConcept C2780214079 @default.
• W2765559122 hasConcept C3018125106 @default.
• W2765559122 hasConcept C71924100 @default.
• W2765559122 hasConcept C98274493 @default.
• W2765559122 hasConceptScore W2765559122C118552586 @default.
• W2765559122 hasConceptScore W2765559122C136229726 @default.
• W2765559122 hasConceptScore W2765559122C141071460 @default.
• W2765559122 hasConceptScore W2765559122C197934379 @default.
• W2765559122 hasConceptScore W2765559122C2777239854 @default.
• W2765559122 hasConceptScore W2765559122C2778375690 @default.
• W2765559122 hasConceptScore W2765559122C2778571141 @default.
• W2765559122 hasConceptScore W2765559122C2779121184 @default.
• W2765559122 hasConceptScore W2765559122C2780214079 @default.
• W2765559122 hasConceptScore W2765559122C3018125106 @default.
• W2765559122 hasConceptScore W2765559122C71924100 @default.
• W2765559122 hasConceptScore W2765559122C98274493 @default.
• W2765559122 hasIssue "48" @default.
• W2765559122 hasLocation W27655591221 @default.
• W2765559122 hasLocation W27655591222 @default.
• W2765559122 hasOpenAccess W2765559122 @default.
• W2765559122 hasPrimaryLocation W27655591221 @default.
• W2765559122 hasRelatedWork W1931187760 @default.
• W2765559122 hasRelatedWork W1999751838 @default.

• next